Facial Enhancement and the European Experience with Sculptra (Poly-L-lactic Acid)
September 2004 | Volume 3 | Issue 5 | Original Article | 542 | Copyright © 2004
By Danny Vleggaar MD, and Ute Bauer MD
The primary reason patients seek aesthetic treatments is to combat the signs of aging. However, the majority of facial treatments and procedures fill specific wrinkles or pull-taught sagging skin, without returning the volume and contours of a youthful face. Injectable poly-L-lactic acid (Sculptra™) is a synthetic, biodegradable polymer, popular in Europe for the correction of lipoatrophy. The novel technique and mechanism of action of this product require physicians to adjust their practice of treating a specific line to returning volume to a facial area. Sculptra™ has been used successfully for the correction of nasolabial folds, mid and lower facial volume loss, jaw line laxity, and other signs of facial aging. Sculptra™ treatment provides a minimally invasive, effective, and prolonged (18-24 months) facial enhancement correction with a low frequency of side effects and no need for allergy testing.
Purchase Original Article
Purchase a single fully formatted PDF of the original manuscript as it was published in the JDD.
Download the original manuscript as it was published in the JDD.
Contact a member of the JDD Sales Team to request a quote or purchase bulk reprints, e-prints or international translation requests.
To get access to JDD's full-text articles and archives, upgrade here.
Save an unformatted copy of this article for on-screen viewing.
Print the full-text of article as it appears on the JDD site.→ proceed | ↑ close